These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17918079)

  • 1. A step closer to extreme drug resistance (XDR) in gram-negative bacilli.
    Paterson DL; Doi Y
    Clin Infect Dis; 2007 Nov; 45(9):1179-81. PubMed ID: 17918079
    [No Abstract]   [Full Text] [Related]  

  • 2. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.
    Falagas ME; Karageorgopoulos DE
    Clin Infect Dis; 2008 Apr; 46(7):1121-2; author reply 1122. PubMed ID: 18444833
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology of multiresistance in Gram-negative non-fermenting bacilli].
    Calvo J
    Rev Esp Quimioter; 2006 Mar; 19(1):86. PubMed ID: 16688299
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial resistance of Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Arya SC; Agarwal N
    Saudi Med J; 2004 Sep; 25(9):1305. PubMed ID: 15448801
    [No Abstract]   [Full Text] [Related]  

  • 5. Correct use of the term 'pan-drug-resistant' (PDR) Gram-negative bacteria.
    Falagas ME; Kasiakou SK
    Clin Microbiol Infect; 2005 Dec; 11(12):1049-50. PubMed ID: 16307565
    [No Abstract]   [Full Text] [Related]  

  • 6. High level resistance in gram negative bacilli.
    Gupta N; Aparna ; Saini S; Arora DR
    Indian J Pathol Microbiol; 2004 Oct; 47(4):594-5. PubMed ID: 16295409
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].
    Grigore L
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):151-60. PubMed ID: 9116405
    [No Abstract]   [Full Text] [Related]  

  • 9. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.
    Cornaglia G; Akova M; Amicosante G; Cantón R; Cauda R; Docquier JD; Edelstein M; Frère JM; Fuzi M; Galleni M; Giamarellou H; Gniadkowski M; Koncan R; Libisch B; Luzzaro F; Miriagou V; Navarro F; Nordmann P; Pagani L; Peixe L; Poirel L; Souli M; Tacconelli E; Vatopoulos A; Rossolini GM;
    Int J Antimicrob Agents; 2007 Apr; 29(4):380-8. PubMed ID: 17223319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gram-negative bacilli isolated in a general hospital: high rate of ciprofloxacin resistance].
    García del Busto Remón A; Pardo F; Moreno R; Galiano JV
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):276-7. PubMed ID: 9044652
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Rahal JJ
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we stem the rising tide of multidrug-resistant gram-negative bacilli?
    Maragakis LL; Perl TM
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):338-40. PubMed ID: 20175689
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic heterogeneity: should we use it?
    Kollef MH
    Crit Care Med; 2003 Jul; 31(7):2074-6. PubMed ID: 12847408
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
    Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
    Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-fermentative Gram-negative bacteria.
    Enoch DA; Birkett CI; Ludlam HA
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S33-41. PubMed ID: 17659210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of multiresistant bacteria in German intensive care units.
    Meyer E; Gastmeier P; Schwab F
    J Antimicrob Chemother; 2008 Dec; 62(6):1474-6. PubMed ID: 18794158
    [No Abstract]   [Full Text] [Related]  

  • 18. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
    Maltezou HC
    Int J Antimicrob Agents; 2009 May; 33(5):405.e1-7. PubMed ID: 19095416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.